Centogene

Centogene is a commercial-stage company focused on rare diseases, dedicated to transforming real-world clinical and genetic data into useful information for patients, doctors, and pharmaceutical companies. Centogene is a global leader in genetic diagnostic testing for rare inherited diseases, with an extensive testing portfolio covering over 2,800 genes, biochemical tests, biomarkers, clinical whole exome sequencing, and whole genome sequencing. Centogene's mission is to support healthcare professionals with deep medical expertise in diagnosing the causes of patient burden as early as possible. By analyzing samples from around the world, Centogene continuously expands its unique portfolio, resulting in the largest genetic findings system record, named CentoMD®. This mutation database integrates genetic and clinical information, enabling the highest quality, knowledge-based genetic testing and biomarker development. In addition to providing diagnostic services for individual patients, Centogene is also a key partner to some of the most respected brands in the industry.